nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2D6—Parkinson's disease	0.9	1	CbGaD
Pyrimethamine—DHFR—Metabolism of nitric oxide—GCH1—Parkinson's disease	0.00931	0.0947	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism of folate and pterines—MTHFR—Parkinson's disease	0.00424	0.0432	CbGpPWpGaD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MCCC1—Parkinson's disease	0.00324	0.033	CbGpPWpGaD
Pyrimethamine—Lamotrigine—ABCB1—Parkinson's disease	0.00205	1	CrCbGaD
Pyrimethamine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.00197	0.0201	CbGpPWpGaD
Pyrimethamine—CYP2C8—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.00182	0.0185	CbGpPWpGaD
Pyrimethamine—DHFR—One Carbon Metabolism—MTHFR—Parkinson's disease	0.00171	0.0174	CbGpPWpGaD
Pyrimethamine—CYP2C8—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00167	0.017	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—Parkinson's disease	0.00161	0.0163	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—INSR—Parkinson's disease	0.00155	0.0158	CbGpPWpGaD
Pyrimethamine—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—Parkinson's disease	0.00154	0.0156	CbGpPWpGaD
Pyrimethamine—DHFR—Fluoropyrimidine Activity—MTHFR—Parkinson's disease	0.0015	0.0153	CbGpPWpGaD
Pyrimethamine—CYP2C9—CYP2E1 reactions—CYP2D6—Parkinson's disease	0.00148	0.0151	CbGpPWpGaD
Pyrimethamine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00138	0.014	CbGpPWpGaD
Pyrimethamine—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00137	0.0139	CbGpPWpGaD
Pyrimethamine—CYP2C9—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.00136	0.0138	CbGpPWpGaD
Pyrimethamine—CYP2C8—Xenobiotics—CYP2D6—Parkinson's disease	0.00113	0.0115	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—SOD1—Parkinson's disease	0.00109	0.0111	CbGpPWpGaD
Pyrimethamine—CYP2C8—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00109	0.0111	CbGpPWpGaD
Pyrimethamine—CYP2C8—Xenobiotics—CYP2E1—Parkinson's disease	0.00103	0.0105	CbGpPWpGaD
Pyrimethamine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00101	0.0103	CbGpPWpGaD
Pyrimethamine—CYP2C8—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000994	0.0101	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—SOD2—Parkinson's disease	0.000979	0.00996	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—GPX1—Parkinson's disease	0.000934	0.0095	CbGpPWpGaD
Pyrimethamine—CYP2C9—Xenobiotics—CYP2D6—Parkinson's disease	0.00092	0.00935	CbGpPWpGaD
Pyrimethamine—CYP2C9—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.000885	0.009	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—MTHFR—Parkinson's disease	0.000862	0.00877	CbGpPWpGaD
Pyrimethamine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000849	0.00863	CbGpPWpGaD
Pyrimethamine—CYP2C9—Xenobiotics—CYP2E1—Parkinson's disease	0.000841	0.00856	CbGpPWpGaD
Pyrimethamine—DHFR—Retinoblastoma (RB) in Cancer—ABL1—Parkinson's disease	0.000832	0.00846	CbGpPWpGaD
Pyrimethamine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000816	0.0083	CbGpPWpGaD
Pyrimethamine—CYP2C9—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000809	0.00823	CbGpPWpGaD
Pyrimethamine—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—Parkinson's disease	0.000691	0.00703	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—INS—Parkinson's disease	0.000686	0.00697	CbGpPWpGaD
Pyrimethamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00055	0.0056	CbGpPWpGaD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000519	0.00527	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000512	0.00521	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—IL1B—Parkinson's disease	0.000512	0.0052	CbGpPWpGaD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000483	0.00492	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000469	0.00477	CbGpPWpGaD
Pyrimethamine—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000463	0.00471	CbGpPWpGaD
Pyrimethamine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000451	0.00459	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle, Mitotic—DCTN1—Parkinson's disease	0.00044	0.00447	CbGpPWpGaD
Pyrimethamine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00043	0.00437	CbGpPWpGaD
Pyrimethamine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000429	0.00437	CbGpPWpGaD
Pyrimethamine—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000424	0.00431	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00042	0.00427	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000417	0.00424	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—VPS35—Parkinson's disease	0.000413	0.0042	CbGpPWpGaD
Pyrimethamine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000393	0.004	CbGpPWpGaD
Pyrimethamine—DHFR—Cell Cycle—DCTN1—Parkinson's disease	0.000393	0.004	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MCCC1—Parkinson's disease	0.000384	0.0039	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000382	0.00388	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000381	0.00387	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000377	0.00383	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—TNF—Parkinson's disease	0.000371	0.00378	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TALDO1—Parkinson's disease	0.000361	0.00367	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—OMD—Parkinson's disease	0.000361	0.00367	CbGpPWpGaD
Pyrimethamine—CYP2C8—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00036	0.00367	CbGpPWpGaD
Pyrimethamine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000352	0.00358	CbGpPWpGaD
Pyrimethamine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000349	0.00355	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000348	0.00354	CbGpPWpGaD
Pyrimethamine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000348	0.00354	CbGpPWpGaD
Pyrimethamine—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000345	0.00351	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MCCC1—Parkinson's disease	0.000321	0.00327	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ND3—Parkinson's disease	0.000321	0.00327	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00031	0.00315	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTA4—Parkinson's disease	0.000305	0.0031	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TALDO1—Parkinson's disease	0.000302	0.00307	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—OMD—Parkinson's disease	0.000302	0.00307	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000301	0.00306	CbGpPWpGaD
Pyrimethamine—DHFR—Folate Metabolism—IL6—Parkinson's disease	0.0003	0.00305	CbGpPWpGaD
Pyrimethamine—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000293	0.00298	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TAF1—Parkinson's disease	0.000291	0.00296	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FBP1—Parkinson's disease	0.000291	0.00296	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NDUFB11—Parkinson's disease	0.000286	0.00291	CbGpPWpGaD
Pyrimethamine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000286	0.00291	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000286	0.00291	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000283	0.00288	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GCH1—Parkinson's disease	0.000273	0.00278	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—MAOB—Parkinson's disease	0.000272	0.00277	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000251	0.00255	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000248	0.00253	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000247	0.00251	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000245	0.00249	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—FBP1—Parkinson's disease	0.000244	0.00248	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—DBH—Parkinson's disease	0.000244	0.00248	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GBA—Parkinson's disease	0.000244	0.00248	CbGpPWpGaD
Pyrimethamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000235	0.00239	CbGpPWpGaD
Pyrimethamine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000233	0.00237	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—SNCA—Parkinson's disease	0.000233	0.00236	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RPL6—Parkinson's disease	0.000233	0.00236	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000223	0.00227	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000221	0.00225	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	0.000202	0.00206	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000199	0.00203	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.000185	0.00188	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000182	0.00185	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—DDC—Parkinson's disease	0.000179	0.00182	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RPL14—Parkinson's disease	0.000176	0.00179	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RPL23A—Parkinson's disease	0.000176	0.00179	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000169	0.00172	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTA4—Parkinson's disease	0.000169	0.00172	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000165	0.00167	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—FGF20—Parkinson's disease	0.000164	0.00167	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—RPS8—Parkinson's disease	0.000164	0.00167	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000162	0.00165	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.000153	0.00156	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.000152	0.00155	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.000152	0.00155	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PLA2G6—Parkinson's disease	0.000152	0.00155	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000152	0.00154	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.000151	0.00154	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MAOB—Parkinson's disease	0.00015	0.00153	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.00015	0.00153	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00015	0.00153	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00015	0.00152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000148	0.00151	CbGpPWpGaD
Pyrimethamine—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.00014	0.00142	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000138	0.00141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000138	0.0014	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000126	0.00128	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000125	0.00127	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000125	0.00127	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000125	0.00127	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000124	0.00126	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000124	0.00126	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.000124	0.00126	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000123	0.00125	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000122	0.00124	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—ADRBK1—Parkinson's disease	0.000121	0.00123	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—HSPA1A—Parkinson's disease	0.00012	0.00122	CbGpPWpGaD
Pyrimethamine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000115	0.00117	CbGpPWpGaD
Pyrimethamine—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000114	0.00116	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000113	0.00115	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000112	0.00114	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP2D6—Parkinson's disease	0.000112	0.00114	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CTGF—Parkinson's disease	0.00011	0.00112	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYP2E1—Parkinson's disease	0.000102	0.00104	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NQO1—Parkinson's disease	0.000101	0.00103	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—TH—Parkinson's disease	9.97e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ND3—Parkinson's disease	9.93e-05	0.00101	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MCCC1—Parkinson's disease	9.93e-05	0.00101	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—CYCS—Parkinson's disease	9.57e-05	0.000973	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—OMD—Parkinson's disease	9.34e-05	0.00095	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TALDO1—Parkinson's disease	9.34e-05	0.00095	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	8.85e-05	0.0009	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.59e-05	0.000873	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—COMT—Parkinson's disease	8.48e-05	0.000862	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCH1—Parkinson's disease	8.45e-05	0.000859	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTP1—Parkinson's disease	8.44e-05	0.000858	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MAOA—Parkinson's disease	8.42e-05	0.000856	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—HMOX1—Parkinson's disease	8.32e-05	0.000846	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MTHFR—Parkinson's disease	8.18e-05	0.000832	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.16e-05	0.000829	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ND3—Parkinson's disease	8.16e-05	0.000829	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ND3—Parkinson's disease	8.08e-05	0.000822	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MCCC1—Parkinson's disease	8.08e-05	0.000822	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ABCB1—Parkinson's disease	7.99e-05	0.000812	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GSTM1—Parkinson's disease	7.75e-05	0.000788	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—OMD—Parkinson's disease	7.67e-05	0.00078	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.67e-05	0.00078	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	7.62e-05	0.000775	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—APOE—Parkinson's disease	7.62e-05	0.000774	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TALDO1—Parkinson's disease	7.6e-05	0.000773	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—OMD—Parkinson's disease	7.6e-05	0.000773	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—DBH—Parkinson's disease	7.53e-05	0.000765	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—FBP1—Parkinson's disease	7.53e-05	0.000765	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GBA—Parkinson's disease	7.53e-05	0.000765	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—GPX1—Parkinson's disease	7.42e-05	0.000755	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.27e-05	0.000739	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	7.21e-05	0.000733	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.93e-05	0.000705	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCH1—Parkinson's disease	6.87e-05	0.000699	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—MTHFR—Parkinson's disease	6.85e-05	0.000697	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—INS—Parkinson's disease	6.51e-05	0.000662	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—APOE—Parkinson's disease	6.38e-05	0.000649	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.2e-05	0.00063	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GBA—Parkinson's disease	6.18e-05	0.000628	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.18e-05	0.000628	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—DBH—Parkinson's disease	6.18e-05	0.000628	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—FBP1—Parkinson's disease	6.13e-05	0.000623	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—DBH—Parkinson's disease	6.13e-05	0.000623	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GBA—Parkinson's disease	6.13e-05	0.000623	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—DDC—Parkinson's disease	5.53e-05	0.000562	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—INS—Parkinson's disease	5.45e-05	0.000554	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA4—Parkinson's disease	5.22e-05	0.000531	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	5.15e-05	0.000524	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	4.7e-05	0.000478	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MAOB—Parkinson's disease	4.65e-05	0.000473	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—DDC—Parkinson's disease	4.54e-05	0.000461	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—DDC—Parkinson's disease	4.5e-05	0.000457	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	4.43e-05	0.00045	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.28e-05	0.000436	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA4—Parkinson's disease	4.25e-05	0.000432	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.19e-05	0.000426	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.86e-05	0.000392	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.82e-05	0.000389	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.82e-05	0.000388	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.79e-05	0.000385	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.6e-05	0.000366	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	3.46e-05	0.000351	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CTGF—Parkinson's disease	3.39e-05	0.000345	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	3.16e-05	0.000321	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NQO1—Parkinson's disease	3.13e-05	0.000318	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TH—Parkinson's disease	3.08e-05	0.000313	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYCS—Parkinson's disease	2.96e-05	0.000301	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—Parkinson's disease	2.84e-05	0.000289	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.81e-05	0.000286	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.79e-05	0.000283	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.76e-05	0.000281	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—COMT—Parkinson's disease	2.62e-05	0.000266	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—Parkinson's disease	2.61e-05	0.000265	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MAOA—Parkinson's disease	2.6e-05	0.000264	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.6e-05	0.000264	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.57e-05	0.000262	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—Parkinson's disease	2.57e-05	0.000261	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.57e-05	0.000261	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.54e-05	0.000259	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TH—Parkinson's disease	2.53e-05	0.000257	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TH—Parkinson's disease	2.51e-05	0.000255	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCB1—Parkinson's disease	2.47e-05	0.000251	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.43e-05	0.000247	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.41e-05	0.000245	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—Parkinson's disease	2.4e-05	0.000244	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—Parkinson's disease	2.29e-05	0.000233	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—COMT—Parkinson's disease	2.15e-05	0.000219	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.14e-05	0.000218	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.14e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—COMT—Parkinson's disease	2.13e-05	0.000217	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.12e-05	0.000216	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—Parkinson's disease	2.12e-05	0.000215	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.12e-05	0.000215	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.11e-05	0.000215	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.09e-05	0.000213	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.03e-05	0.000206	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCB1—Parkinson's disease	2.01e-05	0.000204	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOE—Parkinson's disease	1.97e-05	0.0002	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.97e-05	0.0002	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.95e-05	0.000198	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.88e-05	0.000192	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.87e-05	0.00019	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.74e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.72e-05	0.000175	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—INS—Parkinson's disease	1.68e-05	0.000171	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.62e-05	0.000165	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOE—Parkinson's disease	1.6e-05	0.000163	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—INS—Parkinson's disease	1.38e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—INS—Parkinson's disease	1.37e-05	0.000139	CbGpPWpGaD
